Pharmaceuticals | Council For Citizens Against Government Waste
The WasteWatcher: The Staff Blog of Citizens Against Government Waste

Pharmaceuticals

Importing Foreign Drugs Will Not Lower Drug Costs

This morning, the Department of Health and Human Services (HHS) announced a Notice of Proposed Rule Making (NPRM) to review two potential ways to allow “safe” importation of certain drugs originally intended for foreign markets.  No secretary of Health and Human Services or commissioner of the Food and Drug Administration (FDA) under a Republican or Democratic administration has ever confirmed that importing pharmaceuticals would keep Americans safe from da

Is the Prescription Drug Pricing Reduction Act Another Obamacare?

For weeks, there was little information on what would be in the legislation since it was being discussed and written behind closed doors.

Socialist Drug Price Controls Should be Rejected

It has been often said that in Washington, D.C. bad news comes out on a Friday afternoon and today, July 19, 2019, is no exception

Senate Finance Committee Drug Pricing Changes - Market Driven or More Destructive Price Controls?

The healthcare policy community is anxiously waiting to see what kind of pharmaceutical pricing legislation Senate Finance Committee Chairman Chuck Grassley (R-Iowa) and Ranking Member Ron Wyden (D-Ore.) will produce for Medicare and Medicaid drug plans when Congress returns from the Independence Day break.  Will the shallow, but damaging, policy of instituting price controls be utilized or will enhanced competitive private-sector negotiations be allowed to take hold?  Because competition always leads to lower costs and more innovation, Citizens Against Government Waste (CAGW) hopes it is t

House Speaker Pelosi's Bizarre Drug Price Negotiation Plan

Speaker Nancy Pelosi (D-Calif.) is expected to soon release her long-awaited drug pricing proposal.  According to news reports, the plan is expected to require the Department of Health and Human Services (HHS) to directly “negotiate” with pharmaceutical manufacturers for an “acceptable” price for at least 25 drugs that would apply to the entire U.S. market.  If no agreement can be reached, the Government Accountability Office would act as an arbitrator and oversee a dispute resolution.

U.S. Should Not Import Foreign Price Controls on Drugs

On May 20, 2019, Health and Human Services (HHS) Secretary Alex Azar, spoke before the 72nd World Health Assembly, the decision-making body of the World Health Organization (WHO) under the United Nations (UN), in Geneva, Switzerland. This assembly is held annually and attended by delegations from the 150 WHO member states, including the United States.

Higher Taxes on Pharmaceuticals Will Not Solve the Opioid Crisis

It is common knowledge that addiction to opioids and other controlled substances such as fentanyl is a national epidemic that needs to be addressed.  But, the plans being offered by Minnesota Governor Tim Waltz and the state legislature will drive up pharmaceutical costs, hurt patients, and fail to solve the opioid crisis in Minnesota.

They’re Baaaaack – The Sequel

In their never-ending quest to run roughshod and exert control over the research-intensive biopharmaceutical industry, socialists in Congress have introduced various price-control bills.  For some reason they continue to think innovative drugs that cure cancer or other chronic diseases, such as hepatitis C, are whipped up in a back room with a 1970s-style “

Using an International Pricing Index is NOT the Way to Lower Drug Costs

On December 6, John O’Brien, the senior advisor on drug pricing reform to Health and Human Services (HHS) Secretary Alex Azar, published a blog, entitled, “How the IPI Model Would Introduce New Market Competition to Medicare Drug Spending.”  The blog left a lot of fiscal conservatives and patient-centered, free-market healthcare advocates scratching their heads.  Mr.

New HHS Transparency Regulation Mandates Inaccurate Information

The Pharmaceutical Research Manufacturers Association (PhRMA), the trade association that represents the nation’s leading biopharmaceutical research companies, announced a new proposal on Monday regarding direct-to-consumer (DTC) television advertising.  This voluntary agreement by PhRMA members would help patients access more useful information about the cost of their medicines.

Pages

Tired of the Government wasting your Tax Dollars? Take Action Here! (800) BE-ANGRY

View Archives

Posts by Author

Posts by Tag

Big Government (152) Obamacare (85) Congress (84) Healthcare (76) Budget (76) Waste (75) Uncategorized (56) Telecommunications (50) Internet (49) Debt (47) Technology (47) Deficit (44)